Apoptotic Cells for Therapy of Transplant Rejection
The ability of apoptotic cells to serve as a source of alloantigen and to exert immune-regulatory effects on the innate and adaptive immune responses make apoptotic cell-based therapies a promising tool to down-regulate the anti-donor response that causes rejection of transplanted organs. Advances in understanding the mechanisms of interaction between apoptotic cells and antigen-presenting cells, including dendritic cells and macrophages, have provided the basis for the therapeutic harnessing of cells in the early stages of apoptosis to restrain the immune response or promote immunological tolerance. In this chapter, we compiled the available information on the mechanism(s) by which apoptotic cells interact with cells of the immune system and down-regulate the adaptive immune response, the effect of apoptotic cells on organ allograft survival in experimental models, and the potential application of apoptotic cell-based therapies for prevention or treatment of graft rejection and autoimmune disorders.
Unable to display preview. Download preview PDF.
- Chang MK, Bergmark C, Laurila A et al (1999) Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A 96:6353–6358PubMedCrossRefGoogle Scholar
- Gershov D, Kim S, Brot N et al (2000) C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 192:1353–1364PubMedCrossRefGoogle Scholar
- Jacobsen N, Taaning E, Ladefoged J et al (1994) Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor. Lancet 343:800Google Scholar
- Kleinclauss F, Perruch S, Angonin R et al (2001) Intravenous infusion of apoptotic leukocytes facilitates allogeneic hematopoietic cell engraftment after a non-myeloablative conditioning regimen and induces tolerance to donor antigens (abstract). Blood 98:735aGoogle Scholar
- U.S. Organ Procurement and Transplantation Network, Health Resources and Services Administration, and Healthcare Systems Bureau, Rockville, MD; United Network for Organ Sharing, Richmond, VA. Transplants by Donor Type; U.S. Transplants Performed: Jan. 1, 1988—Oct. 31, 2007. Retrieved Jan. 10, 2008 from http://www.optn.org/latestData/rptData.asp
- Vandivier RW, Ogden CA, Fadok VA et al (2002a) Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol 169:3978–3986Google Scholar